Savara (SVRA) Short-Term Debt repayments (2016 - 2017)

Savara (SVRA) reported Short-Term Debt repayments of $368000.0 for Q1 2017, down 96.45% quarter-over-quarter from $10.4 million in Q4 2016.

Savara (SVRA) Short-Term Debt repayments (2016 - 2017) Analysis & Trends

Savara (SVRA) has 2 years of Short-Term Debt repayments data on file, last reported at $368000.0 in Q1 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Short-Term Debt repayments (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	102,000.00
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-482,347.21
10	Savara	1.39 Bn	1.39 Bn	-	-

Download Data